Persistence of Bactericidal Antibodies in Children Aged 7 to 15 Years Who Received a Single Dose of Menactra or Menomune-A/C/Y/W-135 Five Years Earlier.
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide (Primary)
- Indications Meningococcal infections
- Focus Pharmacodynamics
- Sponsors Sanofi
- 03 Feb 2010 Planned number of patients changed from 487 to 234 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual patient number (487) added as reported by ClinicalTrials.gov.